Literature DB >> 1524068

Preventability and severity assessment in reporting adverse drug reactions.

S C Hartwig1, J Siegel, P J Schneider.   

Abstract

Mesh：

Year:  1992        PMID： 1524068

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN： 0002-9289


× No keyword cloud information.
  208 in total

Review 1.  Preventability of drug-related harms - part I: a systematic review.

Authors:  Robin E Ferner; Jeffrey K Aronson
Journal:  Drug Saf       Date:  2010-11-01       Impact factor: 5.606

2.  Adverse drug reactions caused by drug-drug interactions in elderly outpatients: a prospective cohort study.

Authors:  Paulo Roque Obreli-Neto; Alessandro Nobili; André de Oliveira Baldoni; Camilo Molino Guidoni; Divaldo Pereira de Lyra Júnior; Diogo Pilger; Juliano Duzanski; Mauro Tettamanti; Joice Mara Cruciol-Souza; Walderez Penteado Gaeti; Roberto Kenji Nakamura Cuman
Journal:  Eur J Clin Pharmacol       Date:  2012-05-30       Impact factor: 2.953

3.  An observational study of cutaneous adverse drug reactions in a teaching hospital.

Authors:  Deepti Chopra; Vibha Sharma; Rohan Kapoor; Shridhar Dwivedi
Journal:  Int J Clin Pharm       Date:  2015-08-04

Review 4.  Predicting risk of adverse drug reactions in older adults.

Authors:  Amanda Hanora Lavan; Paul Gallagher
Journal:  Ther Adv Drug Saf       Date:  2016-02

5.  Effectiveness of a Multicomponent Quality Improvement Strategy to Improve Achievement of Diabetes Care Goals: A Randomized, Controlled Trial.

Authors:  Mohammed K Ali; Kavita Singh; Dimple Kondal; Raji Devarajan; Shivani A Patel; Roopa Shivashankar; Vamadevan S Ajay; A G Unnikrishnan; V Usha Menon; Premlata K Varthakavi; Vijay Viswanathan; Mala Dharmalingam; Ganapati Bantwal; Rakesh Kumar Sahay; Muhammad Qamar Masood; Rajesh Khadgawat; Ankush Desai; Bipin Sethi; Dorairaj Prabhakaran; K M Venkat Narayan; Nikhil Tandon
Journal:  Ann Intern Med       Date:  2016-07-12       Impact factor: 25.391

6.  Safety and effectiveness of biosimilar of Rituximab CT-P10 in the treatment of cryoglobulinemic vasculitis: the MARBLe study (Mixed cryoglobulinemiA Rituximab BiosimiLar).

Authors:  Caterina Vacchi; Marcella Visentini; Laura Gragnani; Paolo Fraticelli; Antonio Tavoni; Davide Filippini; Francesco Saccardo; Gianfranco Lauletta; Stefania Colantuono; Fabiola Atzeni; Pietro Pioltelli; Andreina Manfredi; Milvia Casato; Anna Linda Zignego; Giuseppe Monti; Maurizio Pietrogrande; Massimo Galli; Marco Sebastiani
Journal:  Intern Emerg Med       Date:  2020-06-10       Impact factor: 3.397

7.  Patterns, predictors and preventability of adverse drug reactions in the coronary care unit of a tertiary care hospital.

Authors:  Padmini Devi; Deepak Y Kamath; Naveen Anthony; Sushma Santosh; Brendan Dias
Journal:  Eur J Clin Pharmacol       Date:  2011-10-19       Impact factor: 2.953

8.  Extrapyramidal Symptoms Probably Related to Risperidone Treatment: A Case Series.

Authors:  Sereen Rose Thomson; Bharti Chogtu; Dipanjan Bhattacharjee; Saurabh Agarwal
Journal:  Ann Neurosci       Date:  2017-07-24

9.  Causality, severity and preventability assessment of adverse cutaneous drug reaction: a prospective observational study in a tertiary care hospital.

Authors:  Padmavathi S; Manimekalai K; Ambujam S
Journal:  J Clin Diagn Res       Date:  2013-12-15

10.  Self-medication with over-the-counter and prescribed drugs causing adverse-drug-reaction-related hospital admissions: results of a prospective, long-term multi-centre study.

Authors:  Sven Schmiedl; Marietta Rottenkolber; Joerg Hasford; Dominik Rottenkolber; Katrin Farker; Bernd Drewelow; Marion Hippius; Karen Saljé; Petra Thürmann
Journal:  Drug Saf       Date:  2014-04       Impact factor: 5.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.